Medical testing device with muscle stimulation cardiac stress test and related methods

The medical testing device addresses the limitations of conventional cardiac stress tests by using muscle stimulators and sensors to induce balanced muscle tension, enabling efficient and accurate cardiac stress testing in various settings, reducing delays and risks, and providing comprehensive diagnostic data.

WO2024233651A1PCT designated stage expired Publication Date: 2024-11-14PEARLMAN & GANZ LLC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/028352
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-08
Filing Date
2024-05-08
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Conventional cardiac stress tests require effort, balance, ambulation, and equipment that are not compatible with concurrent imaging, limiting their diagnostic accuracy and accessibility, especially for elderly or debilitated patients, and often result in delayed diagnosis and increased risk due to the need for specialized laboratories and personnel.

Method used

A medical testing device using muscle stimulator probes and sensors to induce balanced muscle tension without motion, allowing for concurrent imaging and reducing the need for effort, balance, and equipment, enabling cardiac stress testing at the bedside with portable equipment and minimizing risks.

Benefits of technology

The solution enables efficient, safe, and accurate cardiac stress testing that can be performed in various settings, reducing delays and risks, and providing comprehensive diagnostic data without the need for extensive equipment or personnel, while allowing for staged monitoring and imaging at every stage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2024028352_14112024_PF_FP_ABST
    Figure US2024028352_14112024_PF_FP_ABST
Patent Text Reader

Abstract

A medical testing device is presented for performing an effortless cardiac or cardiopulmonary stress test on a given patient. It is designed to detect the presence of non-physiologic, pathologic responses. The medical testing device includes muscle stimulator probes to be positioned on the given patient. Pairs of muscle targets may be selected to stimulate one or more opposing pair(s) of muscles within the given patient. The medical testing device also includes a controller coupled to the muscle stimulator probes and configured to selectively cause stimulation of the muscles within the given patient, and a sensor device coupled to the controller and attached to the given patient. The sensor device is configured to generate one or more medical characteristic(s) of the given patient based upon the stimulation of muscles within the given patient for the cardiac or cardiopulmonary stress test, to identify non-physiologic pathologic responses.
Need to check novelty before this filing date? Find Prior Art

Description

MEDICAL TESTING DEVICE WITH MUSCLE STIMULATION CARDIAC STRESS TEST AND RELATED METHODSRelated Application

[0001] This application is based upon prior filed copending Application No. 63 / 500,740 filed May 8, 2023, the entire subject matter of which is incorporated herein by reference in its entirety.Technical Field

[0002] The present disclosure relates to the field of health testing, and, more particularly, to a cardiac stress device and related methods.Background

[0003] Stress tests, in the context of clinical medical care, constitute physical challenges used to determine the ability to tolerate an elevated workload. The usual focus is on the heart as a diagnostic procedure to see if stress evokes stress-related non-physiologic clinical issues, such as cardiac ischemia (inadequate blood supply for the increased demand). Other non-physiologic areas of interest may include pulmonary hypertension (excess rise is estimated pulmonary pressure) or abnormalities of blood pressure or heart rate or rhythm (e.g., as seen in dysautonomia). Clinical stress tests impose a challenge to the cardiac work that may uncover a pathologic non-physiologic condition posing a threat (e.g., threat of a heart attack), in time for diagnosis and treatment to avert adverse consequences.

[0004] A staged stress test, such as the Bruce Protocol Treadmill stress test, while requiring effort, coordination, cooperation, balance and ability for rapid ambulation uphill, offers an additional value as a severity gauge identifying the lowest stage of heart rate and blood pressure that induces a problem. The most common clinical stress test is a Bruce protocol treadmill exercise test, which requires walking or jogging on a treadmill for 3 minutes at each of several sequential stages as speed and incline increase, so that each successive stage represents a greater challenge. The clinically accepted final target is to achieve the target heart rate of 85% of the predicted maximal heart rate (MHR), where MHR is calculated as MHR=(220-age). A patient can pass the test by achieving the target heart rate without angina (chest discomfort), anginaequivalents (e.g., cardiogenic shortness of breath or low blood pressure) or signs of ischemia (electric changes on the electrocardiogram (ECG), for example, diagnostic ST segment shifts onthe electrocardiogram, or a drop in blood pressure, or serious arrhythmia, or changes in heart wall thickening or motion, through to the peak target level that has been determined as generally sufficient. If the test includes evaluation of pulmonary pressure, then the subject passes that aspect of the test by avoiding a dangerous rise in pulmonary pressure (e.g., abnormal over a mean pressure of 20 at rest or a disproportionate peak pressure over 35 mmHg, severe if over 60 mmHg).

[0005] For further accuracy, sometimes the stress test also includes imaging to check that there is no evidence of ischemia by additional signs of poor blood supply at peak stress compared to rest by examining changes in heart wall motion, wall thickening, or perfusion. The heart rate response is clinically accepted as a reflection of the degree of challenge, although arguably the challenge impact may be better estimated by rate-pressure product (RPP) (RPP = peak heart rate * peak systolic blood pressure), with 20-25 kTorr / min the accepted target range for an adequate challenge by RPP.Summary

[0006] Generally speaking, a cardiac or cardiopulmonary stress test is a medical testing device for performing a cardiac or cardiopulmonary stress test on a given patient. The medical testing device comprises one or more muscle stimulator probes to be positioned on the given patient. A plurality of muscle stimulator probes may be positioned to stimulate a muscle, group of muscles, or opposing pairs of muscles within the given patient. The medical testing device may also include a controller coupled to the muscle stimulator probes and configured to selectively cause stimulation of muscles within the given patient, and at least one sensor device coupled to the controller and attached to the given patient, the at least one sensor device configured to generate a medical characteristic of the given patient designed to detect non-physiologic responses based upon the stimulation of the muscles within the given patient for the cardiac stress test.

[0007] Also, the controller may be configured to selectively cause balanced stimulation of one or more opposing pairs of muscles within the given patient so that the opposing pair of muscles is in tension during the cardiac stress test. The controller may be configured to progressively change stimulation of the muscles within the given patient during the cardiac stress test. The controller may be configured to change stimulation of the muscles based upon the medical characteristic of the given patient.

[0008] In some embodiments, each muscle stimulator probe may comprise a combination of electrical muscle stimulator electrodes, radio frequency muscle stimulators (RFMS) and / or magnetic muscle stimulator (EMMS) probes. The stimuli may utilize pulsed electromagnetic fields (PEMF) or high-intensity focused electromagnetic (HIFEM) technology. The at least one sensor device may comprise a plurality thereof configured to generate a plurality of medical characteristics of the given patient, and the plurality of medical characteristics of the given patient may comprise a blood pressure, a heart rate, and an electrocardiogram. Sensors may also include oxygen and carbon dioxide measurements. The muscle stimulator probes may comprise a plurality thereof to be positioned to stimulate a plurality of muscle groups or opposing pairs of muscles within the given patient. The plurality of opposing pairs of muscles within the given patient may comprise opposing abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in calves, abductors and adductors in chest, and / or abductors and adductors in abdomen, for example.

[0009] Further, the controller may be configured to output a stimulus signal for each muscle or muscle group. The stimulus signal may comprise one of a burst modulated sine wave signal, a monophasic signal, a biphasic signal, a square-wave signal, a triangle-wave signal, a trapezoidwave signal, or a pulse train signal, for example. The controller may be configured to selectively change a level and pattern of the stimulus signal during the cardiac stress test.

[0010] Another aspect is directed to a method for performing a cardiac stress test on a given patient. The method comprises positioning at least one pair of muscle stimulator probes on the given patient, each pair of muscle stimulator probes to be positioned to stimulate an opposing pair of muscles within the given patient, and operating a controller coupled to the at least one pair of muscle stimulator probes to selectively cause stimulation of the opposing pair of muscles within the given patient. The method also includes attaching at least one sensor device to the given patient. The at least one sensor device is coupled to the controller and configured to generate a medical characteristic of the given patient based upon the stimulation of the opposing pair of muscles within the given patient for the cardiac stress test. Another method applies at least one muscle stimulator, with the option of limiting motion of the affected body part with an external cushioning or splint.Brief Description of the Drawings

[0011] FIG. l is a schematic diagram of a first example embodiment of a medical testing device, according to the present disclosure.

[0012] FIG. 2 is a schematic diagram of an arm of a given patient in the medical testing device of FIG. 1.

[0013] FIG. 3 is a schematic diagram of the arm of the given patient in the medical testing device of FIG. 1 with potential positions for electrode pairs.

[0014] FIG. 4A is a schematic diagram of the arm of the given patient in a second example embodiment of the medical testing device, according to the present disclosure.

[0015] FIG. 4B is a schematic diagram of a housing for a muscle stimulator in the medical testing device of FIG. 4A.

[0016] FIG. 5 is a schematic diagram of the arm of the given patient in a third example embodiment of the medical testing device, according to the present disclosure.

[0017] FIG. 6 is a flowchart for operation of the medical testing device, according to the present disclosure.

[0018] FIGS. 7A-7G are schematic diagrams of sensor devices in the medical testing device, according to the present disclosure.

[0019] FIGS. 8A-8B are diagrams of electrocardiographic characteristics in the given patient.Detailed Description

[0020] The present disclosure will now be described more fully hereinafter with reference to the accompanying drawings, in which several embodiments of the invention are shown. This present disclosure may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided as adjuncts to the descriptions so that this disclosure will be thorough and complete, and will fully convey the scope of the present disclosure to those skilled in the art. Like numbers refer to like elements throughout.

[0021] The current invention relates to a medical testing device for performing a cardiovascular and / or pulmonary progressive or staged stress test on a given patient. The medical testing device comprises at least one electrode pair of radio frequency, and / or magnetic muscle stimulator to be positioned on the given patient, each electrode pair, radio frequency, or magnetic musclestimulator to be positioned to stimulate a muscle, muscle group, or an opposing pair within the given patient. Optionally, the region may have motion restricted by an external device such as a splint which adds resistance to the motion, which may contribute to the diagnostic cardiovascular stress. Optionally, the external constrictors may add to vascular resistance and thereby also contribute to the net cardiovascular stress. In the case of opposing pairs of muscles or muscle groups, there is an option to use a controller to cause the opposing pair of muscles within the given patient to activate in a balanced tension. When opposing muscles or muscle groups are activated in a balanced similar degree, the net movement is minimal, known as isometric, which may obviate the use of a splint or other restraint when significant motion is not desired. The medical testing device also may use at least one sensor device coupled to the controller and configured to generate a medical characteristic of the given patient in association with the contraction of muscle or balanced tension of the opposing pair of muscles within the given patient for the cardiac stress test.

[0022] More specifically, the at least one sensor device may comprise a plurality thereof configured to generate a plurality of medical characteristics of the given patient, and the plurality of medical characteristics of the given patient may comprise a blood pressure, a heart rate, and an electrocardiogram, for example. The at least one electrode pair may comprise a plurality thereof to be positioned to stimulate a plurality of muscles or opposing pairs of muscles or groups of muscles within the given patient, and the plurality of muscles within the given patient may comprise abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in calves, abductors and adductors in chest, and abductors and adductors in abdomen, for example.

[0023] In some embodiments, the medical testing device may further comprise a table to receive the given patient in a supine position during the cardiac stress test. The controller may be configured to output a stimulus signal for each of the at least one electrode pair, radio frequency, or magnetic muscle stimulator. The stimulus signal may comprise one of a burst modulated sine wave signal, a square-wave signal, a monophasic signal, a biphasic signal, a triangle-wave signal, a trapezoid-wave signal, or a pulse train signal, for example. The controller may be configured to selectively change a level of a stimulus signal and pattern during the cardiac stress test. For example, the stimulus signal may have a current in a range of 5-150 mA, and a voltage in a range of 50-400 V. Radio frequency stimuli may utilize pulsed or low power non-thermalsettings for frequency, waveform, and energy levels and may utilize frequencies in the range of 1 to 100 kHz versus 0.1 to 10 MHz, Short bursts of pulses with periods of rest in between, biphasic pulse patterns, for example, medium frequency (2500 Hz) delivered in bursts, and other settings may minimize tissue heating.

[0024] Another aspect is directed to a method for performing a cardiac stress test on a given patient. The method includes positioning at least one electrode pair stimulator, radio frequency stimulator, or magnetic stimulator on the given patient, each stimulator to be positioned to stimulate a muscle, a group of muscles, or an opposing pair of muscles within the given patient, and operating a controller coupled to the at least one stimulator with the option to cause one or more muscles to generate tension against a restraint and / or for opposing pairs of muscles within the given patient to activate in a balanced tension. The method may also include positioning at least one sensor device coupled to the controller and to generate a medical characteristic of the given patient during the balanced tension of the opposing pair of muscles within the given patient for the cardiac or cardiopulmonary stress test.

[0025] A method for performing a cardiac or cardiopulmonary stress test on a given patient. The method comprises positioning at least one electrode pair muscle stimulator, radio frequency muscle stimulator, and / or magnetic muscle stimulator on the given patient, each stimulator positioned to stimulate a muscle, muscle group, or an opposing pair of muscles within the given patient, and operating a controller coupled to the at least one stimulator and to cause the muscle or opposing pair of muscles within the given patient to activate muscles. The method also includes positioning at least one sensor device coupled to the controller and to generate a medical characteristic of the given patient in conjunction with the activation of muscles within the given patient for the cardiac stress test.

[0026] Also, the monitoring is linked to alarms for specific conditions. Medical imaging is an adjunct to assessment of the impact of the workload at one or more stages, with the option of motion reduction to facilitate high quality imaging. In some embodiments, feedback is provided to facilitate reproduction of specific views to improve comparisons across different stages of workload. The feedback utilizes guides that may utilize artificial intelligence (e.g., decision trees, random forests, neural networks, auto encoders) to create feedback for optimal reproduction of the desired views. The feedback utilizing techniques of artificial intelligence (e.g., decision trees, random forests, neural networks, auto encoders) offers feedback for optimal reproduction of thecorresponding views for serial comparisons between different stages. Techniques of artificial intelligence (e.g., decision trees, random forests, neural networks, auto encoders) may be applied to provide preliminary results during and / or after the test, with the option of triggering alarms. In particular, the medical testing device may also include a table to receive the given patient in a supine position during the cardiac stress test, and an immobilizer coupled to the table for restraining movement related to muscle stimulation of the given patient

[0027] Referring initially to FIG. 1, a medical testing device 1000 according to the present disclosure is now described. The medical testing device 1000 is for performing a stress test (i.e. a cardiac, cardiovascular and / or pulmonary stress test) on a given patient 1001, for example, used for diagnosing cardiac ischemia, anaerobic threshold, dysautonomia, pulmonary hypertension etc. The medical testing device 1000 comprises a plurality of electrode pair 1002a-1003b to be positioned on the given patient 1001. Each electrode pair 1002a-1003b to be positioned to stimulate a muscle, a group of muscles, or preferably one or more opposing pair(s) of muscles within the given patient 1001.

[0028] The medical testing device 1000 comprises a controller 1004 coupled to the plurality of electrode pairs 1002a-1002b, 1003a-1003b and configured to cause muscles within the given patient 1001 to activate in a balanced tension. Alternatively, or additionally, radio frequency or magnetic muscle stimulation may be applied. The medical testing device 1000 also comprises a plurality of sensor devices 1005a-1005b coupled to the controller 1004 and configured to generate a plurality of medical characteristic of the given patient 1001 during the balanced tension of muscles within the given patient for the cardiac stress test.

[0029] For example, the plurality of medical characteristics of the given patient 1001 may comprise a blood pressure, a heart rate, and an electrocardiogram, and may also include expired carbon dioxide, for example. The plurality of electrode pairs 1002a-1002b, 1003a-1003b, radio frequency, and / or magnetic stimulators is to be positioned to stimulate one or more muscles or muscle groups. In some embodiments, the muscle work is either resisted by an external device acting as a splint, and / or opposing pairs of muscles are activated within the given patient 1001, and the plurality of opposing pairs of muscles or groups of muscles within the given patient may comprise opposing abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in calves, abductors and adductors in chest, and abductors and adductors in abdomen, for example.

[0030] In the illustrated embodiment, the medical testing device 1000 further comprises a table 1006 to receive the given patient 1001 in a supine position during the cardiac stress test. The controller 1004 is configured to output an electrical stimulus signal for each of the plurality of electrode pairs 1002a-1002b, 1003a-1003b. The stimulus signal may comprise one of a burst modulated sine wave signal, a monophasic signal, a biphasic signal, a square-wave signal, a triangle-wave signal, a trapezoid-wave signal, or a pulse train signal, for example. The controller 1004 may be configured to selectively change a level of the stimulus signal during the cardiac stress test. For example, the stimulus signal may have a current in a range of 5-150 mA, and a voltage in a range of 50-400 V.

[0031] Another aspect is directed to a method for performing a cardiac stress test on a given patient 1001. The method includes positioning a plurality of electrode pairs 1002a-1002b, 1003a-1003b on the given patient 1001, each electrode pair to be positioned to stimulate an opposing pair of muscles within the given patient, and operating a controller 1004 coupled to the plurality of electrode pairs 1002a-1002b, 1003a-1003b and to cause the opposing pair of muscles within the given patient to activate in a balanced tension. In addition or in alternative, the muscle stimulus may be delivered by radio frequency or magnetically. The method may also include positioning a plurality of sensor devices 1005a-1005b coupled to the controller 1004 and to generate a medical characteristic of the given patient 1001 during the balanced tension of the opposing pair of muscles within the given patient for the cardiac stress test.

[0032] In typical stress test approaches, a treadmill is generally not compatible with concurrent imaging, so when imaging is utilized, it is generally limited to immediately before and after the treadmill exercise, which limits the detection of image changes to two time points. Supine chemical stress (e.g., by infusion of dobutamine) enables multiple stages of imaging but that imposes greater cost, limited availability, and risks of arrhythmia, vomiting, and other adverse effects. Also, the elderly and debilitated patients may have poor coordination, poor balance, arthritis or other reasons for limited ability to ambulate; they also tend to have greater response to stress, so the embodiments of the present disclosure invention are expected to achieve diagnosis in a greater portion of patients than the treadmill stress test.

[0033] Unfortunately, the treadmill stress test requires heavy equipment, a technician to operate the equipment, and typically a nurse to monitor the changes in vital signs and watch for risk of falling. Additionally, additional personnel for supervision, recording data, and additionalpersonnel for imaging may be needed. The treadmill exercise stress test also requires cooperation, balance, ambulation, effort and ability to voluntarily achieve the goal. It is typically a scheduled study in a dedicated laboratory, and throughput is limited by availability of the laboratory, imaging, chemicals, and the specially trained personnel.

[0034] Over 12 million people present to emergency rooms each year for chest pain, get referred for the stress testing, and may be kept in the emergency room or special holding areas called “chest pain centers” from Friday to Monday awaiting the stress test. Patients in pain may not put in sufficient effort to reach the target heart rate, in which case the study is deemed nondiagnostic. A muscle cramp, arthritis, imbalance, stubbed toe, breathing disorder or other issues may stop the study before reaching the target heart rate. Typically, the patient is held in observation and / or at very limited activity until other forms of stress test can be performed, such as a chemical infusion that speeds up the heart and / or dilates the arteries, with potential side effects of vomiting, dangerous rhythm changes, fainting, air hunger, arrhythmia and death. Patients find the delay of days, sometimes weeks, until study, the effort, the side effects, and needle pokes disturbing, and some die from preventable causes in the interim.

[0035] The principal imaging adjuncts include radioactive material or ultrasound imaging (i.e., echocardiography) generally requiring particular supine positions not available while walking or jogging on a treadmill. Recent advances in echocardiography have miniaturized requirements for a handheld wand (transducer) and a tablet or cell phone, but supine positioning during imaging is still imposed. Supine position also is deemed better for ECG because of changes in heart position in the chest while standing.

[0036] The present disclosure may produce a method for achieving the stress target condition, while obviating balance, ambulation, effort, or needle sticks. The present disclosure may provide compatibility with concurrent imaging, to provide better ECG data, and to enable staged monitoring of the stress response, including the option of imaging at every stage. The present disclosure may miniaturize equipment requirements so the test may be performed at bedside with easily portable equipment obviating the typical delay for access to a dedicated cardiac stress laboratory. By eliminating the need for effort, balance, ambulation or needles, risks are reduced, the test can be performed on a couch or gurney (a simple bed or cot), and support requirements are reduced to ECG plus vital sign monitoring and ACLS training in the vicinity, with optional imaging that can be handheld, so the new stress test could be performed in the emergency roombedside, or in a pharmacy or medical office exam room, by a single person. The duration of the test can be similar to a treadmill test (about 30 minutes), or faster, for example, by taking advantage of the distributed controlled stimuli to enable 2 minute instead of 3 minute stages.

[0037] This document describes systems, methods and devices to enable cardiac stress testing at bedside or on a couch, enabling concurrent imaging, while obviating ambulation, balance, effort, needle sticks or chemicals. Muscles may be activated by pulsed electric, radio frequency, and / or magnetic signals, and the pattern of stimuli may be selected to target deep muscles while reducing or avoiding nerve pain. Muscle stimulation has been utilized in rehabilitation and proved to be well tolerated even in the elderly (See Low-Frequency Electric Muscle Stimulation Combined With Physical Therapy After Total Hip Arthroplasty for Hip Osteoarthritis in Elderly Patients: A Randomized Controlled Trial V Gremeaux, J Renault, L Pardon, G Deley). Muscle stimulation has also been deployed for aesthetics. Muscle stimulation may be achieved by electricity. Radio frequency, or magnetic activation of contraction, applied to muscle or group of muscle, either directly or by transcranial activation of the brain control of the muscle state via the homunculus (the term homunculus is Latin for “little man”- it is used in neurology today to describe a map in the brain of locations corresponding to each part of the body, for example for muscle activation, aka motor control, such that transcranial magnetic stimuli may evoke painless activation of muscles in designated locations).

[0038] In an embodiment, electrodes, radio frequency, and / or electromagnetic devices are placed on muscle groups (e g., opposing abductors and adductors in the upper arms, thighs, calves, and / or chest, abdomen), with transcranial activation as a distinct option. A stimulus pattern can target deep muscle tension, and by including balanced activation in opposition, such stimuli can evoke near motionless involuntary muscle tension increases. For example, asymmetric biphasic electric stimuli limited to 0-90 ms of peak constant power, at 20-100 pulses per second, with pulse width 0.3 to 1 ms suffices to invoke adjustable strength muscle contraction involuntarily. For example, for electric muscle stimulation (EMS) we can use a burst-modulated sinusoidal waveform with a carrier frequency of 2500 Hz, with the bursts delivered at a frequency of 50 Hz, each burst containing 10 sinusoidal cycles, with a pulse width typically set to 200 microseconds. In order to provide incremental stress challenge to the heart by increasing muscle work, focusing on deep muscles by EMS, there are various waveforms and protocols that can be used.

[0039] The square waveform is a commonly used waveform for deep muscle activation in EMS. It provides a rapid rise and fall in current that can produce strong muscle contractions. This waveform can be used with a high-frequency protocol, which involves a rapid on / off cycling of the current, to increase the demand on the heart due to deep muscle activation.

[0040] Burst mode involves a series of high-frequency pulses grouped into bursts, followed by a period of rest. This waveform can be used to activate deep muscles that are difficult to target with other waveforms. It can also be used with a high-intensity protocol to increase the stress challenge to the heart.

[0041] The Russian protocol (e.g., as introduced by Dr. Yakov Kots) involves a mediumfrequency (e.g., 2500 Hz) burst of pulses delivered at a specific frequency and intensity. This protocol can be used to activate deep muscles and produce a strong muscle contraction. It can also be used with a high-frequency protocol to increase the stress challenge to the heart.

[0042] In the following some detail on the specifications of current, voltage, waveform, and modulation in EMS is provided. The current and voltage used in EMS can vary depending on the specific protocol being used and the patient’s individual needs. The current is typically measured in milliamps (mA) and the voltage is measured in volts (V). The intensity of the current is determined by the amplitude of the waveform and the duration of the pulse. The stimulus may be interrupted netting a specific dwell time (percent of time contraction is activated). The intensity of the current used in EMS can range from a low-intensity protocol, which typically uses a current of 5-15 mA, to a high-intensity protocol, which can use a current of up to 100 mA or more. The voltage used in EMS typically ranges from 50 to 400 volts, depending on the specific device being used. The waveform used in EMS can have a significant impact on the results. Some of the commonly used waveforms include: Sine Wave: A smooth, continuous waveform that is effective for targeting specific muscle fibers and producing a gentle contraction;Monophasic Wave: A signal rectified or otherwise limited to only one of positive or negative deviations. Biphasic Wave: a signal with both positive and negative components. Square Wave: A waveform that produces a sharp, sudden contraction of the muscle fibers (This waveform is effective for producing strong muscle contractions and hypertrophy if applied differently repeatedly over time); Triangular Wave: A waveform that produces a gradual rise and fall in the current (This waveform is effective for producing a sustained muscle contraction and can be used for endurance training); and Trapezoidal Wave: A waveform that combines the features of thesquare wave and the triangular wave (This waveform produces a sharp, sudden contraction followed by a sustained contraction).

[0043] Modulation refers to the process of varying the frequency or amplitude of the waveform over time. This can be done to produce different types of muscle contractions and to prevent muscle fatigue. Frequency Modulation: Varying the frequency of the waveform over time can produce different types of muscle contractions. For example, a high-frequency protocol can produce a rapid contraction of the muscle fibers, while a low-frequency protocol can produce a more sustained contraction. Amplitude Modulation: Varying the amplitude of the waveform over time can help prevent muscle fatigue. This is typically done by gradually increasing the intensity of the current over time. The specifications of current, voltage, waveform, and modulation can all be adjusted to produce different types of muscle contractions and degrees of stress on the heart.

[0044] Painless magnetic muscle stimulation (PMMS) can be used to progressively challenge the heart by increasing the strength and / or frequency or dwell time (percent of time contraction is activated) of muscle contractions. To achieve increased strength of contraction, a protocol that gradually increases the intensity of the current over time can be used. PMMS does not deliver current or voltage directly to the body through electrodes as EMS does. Instead, it uses magnetic pulses to stimulate nerves. The specific parameters used in the PMMS protocol will depend on the patient’s individual needs and the specific goals of the treatment. However, some general guidelines can be followed to create a progressive overload protocol that challenges the heart. Radio frequency muscle stimulation (RFMS) energy typically ranges from 0.5 to 10 MHz, with specific frequencies chosen based on the targeted tissue. The power (energy level) delivered is adjusted to avoid excessive heating while achieving desired stimulation or tissue effects. Frequencies below 1 MHz, particularly in the 1 to 200 kilohertz range, avoid tissue heating compared to higher frequencies like 0.5 to 10 MHz. This is because lower frequencies produce less vibrational energy, reducing the friction that generates heat.

[0045] The intensity of the stimuli can be gradually increased over time to create a progressive overload. The waveform can also vary depending on the specific goals of the treatment. A waveform that produces a strong, sustained deep muscle contraction, such as the Russian pulse waveform, offers advantages for deep muscle contraction strength and progressive overload protocols.

[0046] Modulation can be used to vary the frequency or amplitude of the waveform over time to prevent muscle fatigue and create a progressive challenge to the heart. For example, frequency modulation can be used to produce different types of muscle contractions, while amplitude modulation can gradually increase the intensity of the current over time.

[0047] To create a progressive overload protocol, the intensity of the current can be gradually increased over time. For example, the protocol could start with a low-intensity current and gradually increase the intensity by 10-20% every 3 minutes. This would result in a gradual increase in muscle contraction strength and cardiac workload demand, for staged (progress by steps) in the challenge to the heart.

[0048] To increase the stress challenge to the heart and focus on deep muscle activation, the EMS, RFMS, and / or PMMS protocol can be adjusted to increase the intensity and frequency or dwell time (percentage of time activated) of the waveform over time. For example, starting with a low-intensity protocol and gradually increasing the intensity every 3 minutes can provide a progressive stress challenge to the heart from deep muscle activation. Motion and / or strain gauge monitoring can provide feedback to guide keeping the activation results balanced. The strength and duration of the muscle activations are adjustable and in an example embodiment are adjusted automatically by biofeedback.

[0049] In an embodiment, the net muscle work due to the stimuli is incremented every 2 or 3 minutes as needed to elevate the cardiac demand as desired, to correspond to the changes seen with treadmill exercise. Thigh, calf muscle and other muscle groups of the arms, chest, abdomen, shoulders and / or back may optionally be utilized. The total muscle work is distributed, and the sum is greater than with treadmill exercise due to utilization of additional muscle groups such as upper arm muscle pairs in addition to thigh muscle pairs, so the present embodiments can require less work by the legs than a standard treadmill exercise. The stimuli may be delivered in pulsed patterns, to enable interlaced time intervals without stimuli to avoid any interference with ECG recordings and blood pressure recordings. In other embodiments, inflatable constrictors similar to blood pressure cuffs or leg cyclic compression devices can add to circulatory afterload as a contribution to the net stress on the heart. Immobilizers to restrict motion may be simple splints, may be inflatable or deflatable (e.g., to remove spacing between interior beads of Styrofoam to generate stiffness), or a combination, and may serve a dual purpose of motion restriction and afterload augmentation. With immobilization, the need for balanced tension in opposing groupsmay be reduced or obviated, as even a single muscle or group acting in conjunction with an immobilizer can provide isometric activity to contribute to cardiovascular stress. Any muscle activity can contribute to the cardiovascular stress, but isometric (reduced motion) is preferred, for convenience of maintenance of position and avoidance of motion artifacts. As mentioned above, the present embodiments do not require chemicals, needle sticks, ambulation, balance, or volitional effort. Optionally, imaging (e.g., echocardiography) may be included, along with the electrocardiography), optional oximetry and / or carbon dioxide and vital sign monitoring, all of which are completely non-invasive. All of the equipment can fit in a small briefcase.

[0050] There are several differences in the impact on deep muscle stimulation and cardiac challenge for changes in waveform and modulation when comparing EMS, RFMS, PMMS, and combinations. With deep muscle stimulation, EMS is primarily used to stimulate surface muscles, while RFMS and PMMS may target deeper muscles. This is because RFMS penetrates tissues and may be focused, and PMMS uses a magnetic field that can penetrate deeper into the body, allowing it to target deeper muscles that are difficult to reach with EMS alone. When combined, EMS can be used to target surface muscles, while RFMS and / or PMMS can be used to target deep muscles, providing a more comprehensive muscle stimulation.

[0051] The positioning, waveform and modulation used in EMS, RFMS, and PMMS affect the depth of muscle stimulation. For example, square waveforms with high frequency and short pulse durations are typically more effective for targeting surface muscles, while sine or triangular waveforms with lower frequencies and longer pulse durations are more effective for targeting deep muscles.

[0052] EMS, RFMS, and PMMS have been used for purposes of muscle relaxation, strength building, blood flow, and other purposes, but in the present embodiments, they are utilized to provide a cardiac challenge by increasing muscle work and demand on the heart, with a pathologic goal of identifying if there is a level of challenge that invokes cardiac ischemia, pulmonary hypertension or other adverse, non-physiologic consequence. Physiologic processes are those that are normal or natural to the healthy body's function. Non-physiologic or pathologic processes are abnormal and usually associated with disease such as coronary artery disease.

[0053] The impact of each on cardiac challenge can differ depending on the specific protocol used.

[0054] For EMS, high-frequency protocols with short pulse durations and strong amplitudes are typically more effective for producing a cardiac challenge. This is because these protocols produce rapid muscle contractions that induce a high level of cardiovascular demand.

[0055] The Russian pulse waveform has advantages for comfortable deep muscle activation to produce a significant cardiac challenge. The Russian pulse has a longer pulse duration and lower frequency than other waveforms, which allows for a sustained muscle contraction that invokes more cardiovascular demand to maintain.

[0056] When EMS, RFMS and / or PMMS are combined, the waveform and modulation used can be adjusted to target both surface and deep muscles while also providing a significant cardiac challenge. This can be achieved by using a combination of high-frequency protocols and Russian pulse protocols.

[0057] In conclusion, there are differences in the impact on deep muscle stimulation and cardiac challenge when comparing EMS, RFMS, PMMS, and combinations. The specific waveform and modulation used in each can impact the results, with RFMS and PMMS typically providing deeper muscle stimulation and the Russian pulse waveform providing both deep muscle stimulation and a significant cardiac challenge. Either alone or when combined, EMS, RFMS and PMMS can be used to provide comprehensive muscle stimulation while also providing a significant cardiac challenge.

[0058] In the following, the equipment setup for an example embodiment is now described. The effortless stress test requires specialized equipment that generate electric pulses, radio frequency fields and / or magnetic fields to stimulate the muscles. The equipment should be calibrated according to the manufacturer’s instructions and the patient’s individual needs. Proper placement of the electrodes, radio frequency antennas and / or magnet coils is required. Radio frequency antennas and magnet coils may rise somewhat in temperature, but also can be displaced a distance, with optional intervening heat shielding and / or cooling, and / or cooling can be applied. The intervening shielding can also serve as an immobilizer, may be inflatable and / or deflatable, and may also contribute to stress via increased afterload.

[0059] Before starting the protocol, it’s important to warm up the muscles to prevent injury and to improve performance. This can be done through light aerobic exercise, stretching, or using a preliminary low-intensity muscle activation protocol, which also serves to prepare the patient with what to expect.

[0060] The protocol should be designed to gradually increase the strength of muscle contractions over time. This can be achieved by gradually increasing the intensity and / or dwell time of the stimuli, for example, by 10-20% every 3 minutes. The duration of the protocol can vary depending on the patient’s individual needs and goals, but typically ranges 20-30 minutes. The waveform used in the protocol can also be adjusted to achieve different goals. For example, a Russian pulse waveform can be used for deeper muscle activation, while a sinusoidal waveform can be used for muscle recovery. During the protocol, the patient’s response should be closely monitored to ensure safety and effectiveness. Any discomfort or adverse reactions should be addressed immediately. If the patient is not responding well to the protocol, adjustments can be made to the intensity, duration, or waveform to optimize results. After the protocol is complete, a cool-down period is recommended to allow the muscles to recover and prevent injury. This can include stretching, light aerobic exercise, or using a low-intensity sine wave protocol, for example.

[0061] FIG. 2 shows opposition muscle groups and the mechanism of isometric contraction. The arm 100 includes a forearm 101 (lower arm between the wrist and elbow), and an upper arm 102 (between the elbow and shoulder). The arm 100 a wrist flexor muscle region 103 within the forearm containing muscles that flex the face down hand upward at the wrist (known medically as dorsiflexion or wrist extension) and on the opposite side indicates a wrist extensor muscle region 104 with muscles that flex the wrist downward (known medically as plantar flexion, or wrist flexion). Balanced activation of both regions produces isometric contractions (no significant net movement). Similarly, the upper arm 102 includes an anterior muscle group, elbow flexor muscle region 105 that flexes the arm at the elbow, and a posterior muscle group, elbow extensor muscle region 106 that extends the arm at the elbow. Balanced activation of both regions produces isometric contractions (no significant net movement). The legs (not shown) have similar groups of muscles in the calf area for flexion or extension at the ankle, and in the thigh area for flexion or extension at the knee. Again, balanced activation of opposing regions produces isometric contractions (no significant net movement).

[0062] FIG. 3 shows an arm 200 of the given patient 1001 with optional electrode pairs configured to induce isometric muscle contraction. The arm 200 includes a forearm 201 (lower arm) corresponding to 101 in FIG. 2, and an upper arm 202, corresponding to 102 in FIG. 2. The arm 200 has a pair of electrodes 203, 204 applied to the skin such that electric differencebetween the pair would activate muscle below, corresponding to the wrist flexor muscle region103 in FIG. 2. The arm 200 has a pair of electrodes 205, 206 applied to the skin such that electric difference between the pair would activate muscle below, corresponding to the wrist extensor muscle region 104 in FIG. 2. The arm 200 has a pair of electrodes 207, 208 applied to the skin such that electric difference between the pair would activate muscle below, corresponding to the elbow flexor muscle region 105 in FIG. 2. The arm 200 has a pair of electrodes 209, 210 applied to the skin such that electric difference between the pair would activate muscle below, corresponding to the elbow extensor muscle region 106 in FIG. 1.

[0063] FIGS. 4A-4B shows an optional electromagnetic muscle stimulator device (for radio frequency and / or magnetic stimulation) 300 for an arm 310 of the given patient 1001. The arm 310 includes a forearm 301, corresponding to 101 of FIG. 2. This arm 310 includes an upper arm 302, corresponding to 102 of FIG. 2. The arm 310 includes an anterior forearm 303, corresponding to 103 of FIG. 2. The arm 310 includes a posterior forearm 304, corresponding to104 of FIG. 2. The arm 310 includes an anterior upper arm 305, corresponding to 105 of FIG. 2. The arm 310 includes a posterior upper arm 306, corresponding to 106 of FIG. 2.

[0064] This includes a device housing 307 for the stimulator (radio frequency and / or magnetic), and optionally an adjustable encasement to immobilize the limb. The adjustable encasement can include an inner sack containing particles, such as Styrofoam, such that placement around the limb followed by evacuation of air solidifies the unit to form a comfortable removable cast immobilizing the limb. This includes an optional strap 308. This includes a hollow space 309 to accommodate a body portion, such as the posterior forearm 304. The shape of the device housing 307 may vary for comfort or ease of placement, and need not be rectilinear. The housing 307 may be hinged or flexible like a blood pressure cuff. The housing 307 may accommodate both the anterior upper arm 305 and the posterior upper arm 306, either as a single device 307, or as a locking pair of devices (not shown), or as a single slide-on cylinder or bracelet (not shown). The muscle stimulator within the housing 307 may be inductively coupled or it may be energized by an attached cord (not shown).

[0065] FIG. 5 shows optional position, motion and strain detectors. Here, the arm 400 includes the forearm 401, corresponding to 101 of FIG. 2. This includes position and motion sensors 402 and 403, which detect motion and relative motion, and / or position and / or relative position changes. This includes indicates a strain sensor 404 that directly assesses changes in wristextension or flexion. Similar sensors can be placed near the elbow to detect the balance of flexion and extension at the elbow. These are examples of feedback sensors to balance the extensor and flexor muscle group activations to achieve little or no motion from muscle stimulation.

[0066] FIG. 6 includes a flowchart 500 that shows a method for operating and / or decision logic for the controller 1004 of the medical testing device 1000, which begins at Block 501. At Block 502, the settings are set to baseline targets. At Block 503, the method decides whether to increase the stage of stimulation. Blocks 504-506 monitor the plurality of medical characteristics of the given patient 1001 until the stage of stimulation is complete. The method ends at Block 507.

[0067] The method utilizes feedback and elapsed time to actuate and distribute muscle tension with little to no net movement, as well as apply decision logic utilizing measurements to guide completion of each stage and progression to a subsequent stage, adjusting stimulation frequency, duration, amplitude and dwell time, as well as determining when to pause (e.g., if applying echo needs extra time for pulmonary pressure as well as wall motion, with option to pause stimuli and / or extend current stage until notified to proceed), when to increase stage and when to terminate the stress study. The method also includes concurrent observations of any position, strain or other measurements to adjust balance of stimuli, and it utilizes elapsed time, blood pressure, heart rate, user input and electrocardiography data for stop criteria, else it proceeds until goals are met.

[0068] FIG. 7A shows an example embodiment of the controller 1004. Here, the controller 1004 is a master control that manages data storage as well as equipment control and coordination. Optionally it utilizes a smart phone, touch screen, or keyboard and display, such as the illustrated laptop portable computer. Data are HIPAA compliant. In the illustrated embodiment, the controller 1004 registers essential patient information, and computes the goals for 85% of predicted maximal heart rate, with additional options to set criteria for study determination (e.g., if normal baseline then 2 mm ST deviation in 2 adjacent leads, or systolic blood pressure >220 mmHg, or symptoms consistent with angina, with or without at least 1 mm ST shift). Decision information from setup determines criteria for the balance of stimuli at different locations, criteria for adjustments, criteria for ending each stage, and criteria for progression from one stage to the next, as depicted in FIG. 6.

[0069] FIG. 7B shows an exemplary embodiment of the sensor device 1005 comprising a blood pressure sensor. Optionally, it has wireless or wired bidirectional communication with the controller 1004 of FIG. 7A. Outgoing signal from the controller 1004 triggers data collection. The incoming signal captures the measurements with the timestamp and stage, in some embodiments. Alternatively, a user / operator could deploy a manual blood pressure manometer and optionally provide manual input of the measurements, either synchronously or later along with timestamps. A plurality of the blood pressure sensors 1005 can be deployed on the limbs to augment peripheral resistance on demand as a tourniquet with or without the manometry function, as a contribution to augment blood pressure and heart stress as needed.

[0070] FIG. 7C shows an electrode stimulator 1005 from a plurality of stimulators, as in FIG. 3, and one of numerous embodiments of a \ muscle stimulator 310 (e.g., a radio frequency or electromagnet muscle stimulator) as in FIG. 4B. The controller 1004 triggers activation of stimulators in a coordinated fashion in accordance with balance, site and comfort options, as well as stage, to trigger adjustments in strength, duration, dwell time as designated for specific progressive stage goals, adjustable in accordance with heart rate goal and / or blood pressure observations and goals for each stage. Optionally, the stimulation may include any selected combination of electric (electrode stimulator 1005), magnetic (310) and peripheral constrictors (e.g., blood pressure cuff), cycled for comfort and adjusted to maintain stage specific goals.

[0071] Referring to FIG. 7D, several different types of sensor devices 1005 is shown, which includes one of a possible plurality of position sensors 605, a possible plurality of strain (flexionextension) sensors 606, which offer feedback for optional adjustment of the balance of flexor and extensor muscle stimulations, and an oximeter 607 (i.e., device for measurement of oxygen saturation). Optionally an additional device can analyze breath gases, for example, expired carbon dioxide (not shown).

[0072] Referring to FIG. 7E, another embodiment of the sensor device 1005 is now discussed. Here, the sensor device 1005 comprises an electrocardiograph system. In an example embodiment, the electrocardiograph system is a standard 12-lead ECG (diagram 608 shows 12 datapoints), providing data to the controller 1004 of FIG. 7A. The signals from the electrocardiograph system can be reported continually to the controller 1004, timestamped, analyzed and stored as snapshots at specific times and stages. Optionally additional records can be generated if user input or automated ECG interpretation has a reportable observation such asarrhythmia, or significant ST segment shifts. Significant arrhythmia or significant ST shifts from a normal baseline can trigger stoppage (completion) of the stress test.

[0073] Referring to FIGS. 7F-7G, another embodiment of the sensor device 1005 is now discussed. Here, the sensor device 1005 comprises an ultrasound (echo) transducer 609. It is illustrated with a wire but in an example embodiment it is wireless. The sensor device 1005 may include a position sensor and / or positioning device 610 for the ultrasound (echo) transducer, to assist with obtaining comparable views at each stage.

[0074] In an example embodiment, artificial intelligence provides visual feedback to the ultrasound user (cardiac echo user) either on the controller 1004, a smart phone, or other display, to provide images and a check list of data to collect with the option of feedback for the agreement of position and view. Optionally, the images obtained are re-organized by view and analyzed to facilitate recognition of any changes in radial wall motion, wall thickening, changes in synchrony or contractility and other relevant findings.

[0075] FIGS. 8A-8B depict electrocardiographic evidence of cardiac ischemia. Diagram 701 depicts a normal 12-lead ECG with corresponding regions of the heart labelled. Diagram 702 depicts a 12 lead with repolarization changes indicating induced ischemia. Such data are captured by electrocardiograph system and reported to the controller 1004. In an example embodiment a series of ECGs are captured as snapshots that are bundled with timestamped data, including blood pressures, heart rates, images if obtained, and optionally derived graphs and images, along with the option of an automated preliminary interpretation, to create a full report of data, a summary report, and optionally a preliminary interpretation of the results, optionally including recommendations.

[0076] This document describes methods and devices for performing a cardiac and / or pulmonary effortless non-chemical portable stress test. This section describes two example embodiments in detail. The first embodiment is a less costly embodiment and the second details maximal automation, each with a basal configuration and examples of value-added options.

[0077] The first embodiment of the present disclosure need only to produce the staged progression in muscle activation needed to achieve the passive effortless stepwise approach to the diagnostic target of elevating the heart rate progressively from baseline to 85% of the age- predicted maximum. That is achieved with the features of no effort, no needle sticks, no ambulation, no chemicals, by the electric (see Table 1 in Application No. 63 / 500,740 forexample sources), radio frequency, and / or magnetic (see Table 2 in Application No. 63 / 500,740 for example sources) involuntary depolarization of the muscle contractions in large muscle groups, for example, the four limbs, and optionally the pectorals and abdomen as well. Transcranial magnetic activation is a third option.

[0078] In an example embodiment, a device provides the stimulation of deep muscle groups with stepwise adjustments per protocol and instructions that are provided, for staged stepwise increases in cardiac workload demand, along with instructions to collect blood pressure (BP) and 12-lead electrocardiographic data at each stage. The recommended data collections include baseline, each progressive stage of cardiopulmonary stress (dividing the approach to the target heart rate into typically 3-6 stages, as elected by the practitioner), and recovery. The protocol specifies the steps including changes to power, frequency, waveform and dwell time of the muscle stimulations, and when to collect data.

[0079] Optionally the stimulator provides separate balance and level controls, whereby balance adds a shift in amperage delivered to the deep muscles between flexor and extensor target activations to invoke a difference in their respective contraction strengths, whereas level adds equally to both flexors and extensors. Optionally the controller enables changes in waveform, frequency, pulse duration, dwell time, step level and interrupt / pause. Optionally the protocol of muscle stimulations may be computer mediated rather than manually set, optionally with a simple input from the technician indicating readiness to proceed to the next step, for extensible time to complete any ultrasound data collection, on-going data review or attending patient concerns. Optionally the controller receives heartrate information to automate maintenance and scaling of steps as an alternative to manual adjustment of scaling and maintaining the steps in muscle activation strengths for the progressive stages of the stress test. Optionally the settings include a comfort adjustment that shifts the balance between settings such as strength, dwell time and ramp time for each stage, and optionally shifts the work to specific body areas, such as more to the arms, less to the legs. Optionally there are vascular resistance cuffs or external pressure devices to enable a secondary contribution to heart work demand by imposing intermittent augmentation in limb blood flow resistance, such as, calf compression, which may be intermittent, as a complementary contribution to the stress test objective of challenging the heart that reduces the need for strong muscle contractions. The vascular resistance can be passive, orcontrollable, for example, pneumatically, with options of adjusting the degree and duration of constriction and dwell time (ratio of constriction time to release time).

[0080] While balanced contraction can result in no net movement, an example embodiment facilitates absence of motion and provides motion resistance as a contribution to the cardiac work demand by applying an immobilizing external removable encasement such as the rapid-form- vacuum-immobilizer for each leg and each arm involved. For example, the test could utilize sets of “Rapid Form Immobilizer”, which is available from Everything Medical, Address: 1811 W Charleston Blvd. Las Vegas, NV 89102. See Table 3 in Application No. 63 / 500,740 for examples of potential alternatives. The immobilizer stabilizes limbs comfortably without circumferential pressure. Such immobilizers were designed to stabilize fractured limbs but they can serve well for the motionless stress testing of the present embodiments. Once secured around the limb, a pump extracts the air. Inside the immobilizer, Styrofoam beads form a solid mass when the air is extracted, making it rigid, but comfortable, due to exact conformation to the limb.

[0081] If the muscle activation includes transcutaneous electric activation of deep muscles, electrode contacts are placed on the skin under the optional immobilizer. If the muscle activation is induced by radio frequency and / or magnetic fields, a device is placed or wrapped outside the immobilizer and / or optionally outside a heat shield and / or cooling system to generate electromagnetic radiant energy to activate the muscle. If an immobilizer is utilized, that can also serve as temperature shield. The Styrofoam beads also help isolate the limb from any heating of the coils. Whether electric, radio frequency, and / or magnetic activation is utilized, the muscle activation may include pulses of different values of strength, duration, waveform, pattern, and frequency, each of which contributes to the net degree of muscle work.

[0082] A protocol is developed comprising defined values for strength, waveform, frequency, pattern, dwell time and duration sufficient to elevate to and then maintain each of several different levels of muscle activation for each of typically 3 to 6 stages that represent stepwise increases from resting condition up to the achievement of the target heartrate. Each stage may be maintained by intermittent activation sufficient to maintain a steady heartrate for each stage, to provide time for data collection at each stage. The data collection may be performed between muscle activations in case muscle activations may generate artifacts. The minimal value proposition for data collection can be manually executed by a technician or nurse, consisting of any symptoms, blood pressure, 12 lead ECG recordings and other observations. Optionally itmay also include oxygen saturation, expired CO2 and / or echo images of the heart in standard views, and other data. Optionally, it may include Doppler estimation of pulmonary artery pressure based on peak velocity of blood flowing across the tricuspid valve. Unlike treadmill stress echo, the echo data may be collected without rush, and at every stage, not just baseline and peak. Obtaining the data at every stage enables determination of the lowest level of heartrate and rate-pressure product that initiates a non-physiologic, pathologic response, thus providing an assessment of tolerable activity level and severity of the disease in addition to qualitative diagnosis, and it improves safety over a stress test that does not enable the additional measures of impact at every stage, as the test may be stopped as soon as diagnostic changes are observed. Determination of the highest well tolerated stress level if limited below the full target may be useful as guidance for an anesthesiologist during a planned surgical procedure, or to plan an exercise program, to identify when to intercede to avoid sustaining undesired changes such as sustained cardiac ischemia.

[0083] The automated embodiments of the present disclosure incorporates electronically connected devices to collect and store relevant data, for ease of operation, and to enable the additional option of automated technician notification for key abnormalities (e.g., a plurality of heart rate, maximal ST depression, rhythm, blood pressure, oxygen saturation, expired carbon dioxide, wall motion score, estimated pulmonary pressure). The technician operator may use default settings or may elect the number of stages for the test, the duration of each stage, waveform and other stimulation settings, and / or specific alarm criteria. Therefore, an automated embodiment includes a controller (e.g., computer) to control not only the muscle activation protocol, but optionally also data collection and analysis, by deploying devices that electronically report data such as ECG data, blood pressure and / or heart rate, and rhythm, oxygen saturation, expired carbon dioxide, and echo data (e.g., wall motion score, estimated pulmonary pressure) and optionally the assembly and formatting of a report.

[0084] In an example embodiment the technician operator of the effortless stress test system can elect options for the protocol, not limited to selection of waveform and other parameters of muscle stimulation, for example, for patient preference, and selection of the number and duration of stages for the test, for example, 3 stages 3 minutes each for a relatively fast test, 6 stages for a slower test when threshold of ischemia is a primary goal, such as with purported asymptomaticaortic stenosis evaluation, or an angina threshold test for safety criteria, for example, in planning limitation of heart rate for non-cardiac surgery or for an exercise program.

[0085] In an example embodiment the computer or controller is informed of the patient age or birthdate and on observing the resting heartrate it then computes the step size for heart rate increments from the requested steps (S = the number of stages) and the target range (TR = THR - BHR), where THR=target heartrate, BHR = baseline heartrate, maximal predicted heartrate is routinely computed as (MHR=220-age) and target heartrate as (THR=85% MHR), to compute the staged goals as incrementing from baseline by the target step size TS calculated as (TS=TR / S). Thus, the target heartrate THR for each stage is calculated as (THR=BHR + stage * TS). The computer then implements the protocol when instructed to start the test by applying muscle stimuli in a graded escalation of the selected combination of waveform, strength, dwell time and frequency, until the target THR is achieved as reported by the heartrate, then it switches to maintenance of that rate for the duration of each stage, for example, 3 minutes. During the last minute of each stage, data is collected. In an example embodiment the data collection is triggered by the computer, while stimulation is in one or more pauses. In an example embodiment, the data are presented to the technician operator, along with the stage goal, along with computer measurements and flags for any computed abnormality.

[0086] The electronically reported data may be analyzed by the controller to utilize as feedback to automatically make adjustments for each stage. That also enables the option of actuating a technician notification indicator or alarm for abnormalities. Devices are available that may be electronically activated as well as report results electronically, for automated control of data collection as well as automated analysis and annotated data storage. Examples of potential choices for such devices are listed in the tables. Therefore, an automated embodiment can have the controller implement the selected protocol, simplifying the role of the technician to consent / communication, placement of the equipment, activating the test, observing through completion (until the induction of ischemia or achievement of adequate heart rate without ischemia, or other endpoint), and then removing the equipment.

[0087] Software has been demonstrated reliable in analyzing ECG signals to detect onset of inducible cardiac ischemia (inadequate blood supply) or lack thereof (see FIGS. 8A-8B). The patient may utilize a push button and / or voice to report any symptoms. The technician operator may stop the test at any point in time.

[0088] In addition to determination of the presence or absence of inducible ischemia, the present embodiments also may be utilized to assess heart rate and blood pressure response to demands, and other non-physiologic, pathologic responses, relevant to other clinical concerns such as dysautonomia or pulmonary hypertension or ischemia threshold. Whereas chemical stress tests require intravenous access and may cause side effects ranging from discomfort to possible death, and whereas standard exercise protocols require balance, coordination, patient concentration and cooperation to achieve sufficient progressive effort, the present embodiments achieve the cardiopulmonary challenge from staged effortless stress stimulations for diagnostic purposes, which can be mediated by signals to the brain (transcranial), or in some embodiments, directed to muscle.

[0089] FIG. 2 depicts the option of engaging opposing adductors and abductors (flexion vs extension, bending vs straightening) such that balanced tension in the opposing groups results in no significant net movement, despite significant muscle activation. The muscle activation increases demand on the heart to circulate oxygenated blood to all involved muscles as their elevated metabolic activity triggers vasodilation and increased demand for increased blood flow. Inflation of restrictive cuffs on limbs and electric stimulation provides additional means to increase heart rate and / or blood pressure as a clinical challenge test.

[0090] The present embodiments are based on the fact that the pathophysiology of increasing the challenge on the heart, to get it to beat faster and stronger, can reveal the presence of inducible ischemia or other untoward non-physiologic outcome such as pulmonary hypertension, dysautonomia or extreme changes in blood pressure. While existing stress tests rely on exercise effort and / or chemicals, the present embodiments enable achieving the stress passively in progressive stages, without patient effort or chemicals. The dwell time (percent of time contraction is activated), the pattern and strength of stimulation, and distribution to different muscle groups, are adjustable which enables a comfortable progressive graded response. Position and strain sensors can be utilized for automated determination of balance of muscle activations to provide feedback to avoid evoking net motion, or the limbs may simply be immobilized by external devices.

[0091] In an example embodiment, the equipment comprises a plurality of muscle stimulators coordinated by a control unit that also manages the collection of data that includes blood pressure, heart rate, and electrocardiograms. An expanded embodiment also monitors oxygensaturation and expired carbon dioxide. In an example embodiment, the rate and any ST segment shifts on the electrocardiograms are measured automatically, linked to preset criteria to determine the pattern and strength of muscle stimulation, and consequences, as well as when to increase and when to stop the stimulation. In an example embodiment, the patient has a button or switch or voice control to stop the study on demand.

[0092] In an example embodiment, position, motion, acceleration and / or strain monitors provide feedback to maintain balance in activation of extensors and abductors, to reduce or minimize motion. In an example embodiment, the combination of distribution, duration, pattern, frequency, and amplitude of stimuli for each stage of stress testing may be adjusted to preference while maintaining stage goals. In an example embodiment, the goals of stimulation for the heart rate and / or rate-pressure product targets may be switched from incremental to maintenance during acquisition of data, to extend time as needed for echo imaging for a specific stage, and to accommodate pauses in stimulation to counter any contribution to artifacts in ECG or imaging. The stimulation may include any combination of stimuli, for example, electric, radio frequency, magnetic, and / or dynamic compression of limbs (tourniquet augmentation of peripheral resistance, which can be mediated by blood pressure cuffs or other dynamic constrictors with or without manometry).

[0093] In an example embodiment, the patient and / or an observer will be presented a summary of monitoring information, such as percent of progress to target achievement (until completion of stress goal), as a number, progress bar, needle (like a car fuel or charge gage indicator) and / or one or more color and / or pattern indicator(s).

[0094] In an example embodiment, monitoring will include image probe position and / or similarity of view, as a guide to reproducing comparable views accurately. Analysis of position device and / or images, both historic and individual active case, for each of the cardinal views, may include the option of measuring the impact of graded tilts, rotations, and shift in placement, and can be used as training data for computations (e.g., decision trees, random forests, neural networks, auto encoders) to create feedback for optimal reproduction of the desired views for serial comparison at each stage. Typically, the views include short axis, 4-chamber long axis, and 2-chamber long axis views, from parasternal and apical chest wall positions, respectively. Optionally 2 transducers may be used, one for parasternal and one for apical views, optionally maintained in position by transducer holders (see Tables 5 and 6 in Application No. 63 / 500,740).

[0095] In an example embodiment, analysis of data will be automated to generate a preliminary and / or final report. In particular, analysis of ST shifts can be computed and presented, optionally along with symptoms, blood pressure, rhythm, rate, QRS changes, ECG tracings, pulmonary pressure estimates, wall motion, wall thickening, contraction timing and other measurements.

[0096] The system can provide automatic, graceful, and emergency stop options. Automatic stop is based on achieving goals for the study. Graceful stop ends on the current stage. Emergency stop shuts off stimuli immediately. Hold extends the current stage with maintenance stimulation to sustain the current heart rate / cardiac workload (useful for additional imaging or other evaluations).

[0097] Referring again to FIG. 1, a medical testing device 1000 (i.e., a cardiac assessment system) is for performing a cardiac stress test on a given patient 1001. The medical testing device 1000 comprises a plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a- 1003b to be positioned / attached respectively to a plurality of muscles or opposing pairs of muscles on the given patient 1001. Each pair of muscle stimulator probes 1002a-1002b, 1003a- 1003b is to be positioned to stimulate muscles within the given patient 1001. The plurality of opposing pairs of muscles within the given patient 1001 may comprise opposing abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in chest, and / or abductors and adductors in abdomen, for example

[0098] The medical testing device 1000 also includes a controller 1004 coupled to the plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b and configured to selectively cause stimulation of preferably opposing pair of muscles within the given patient 1001. The controller 1004 may comprise a stand-alone computing device in some embodiments, or in other embodiments, the controller may comprise an application specific integrated circuit within a purpose built medical testing device.

[0099] The medical testing device 1000 illustratively includes a plurality of sensor devices 1005a-1005b coupled to the controller 1004 and attached to the given patient 1001. The plurality of sensor devices 1005a-1005b is configured to generate a plurality of medical characteristics of the given patient 1001 based upon the stimulation of the opposing pair of muscles within the given patient for the cardiac stress test. The plurality of medical characteristics of the given patient 1001 may comprise a blood pressure, a heart rate, and an electrocardiogram. Of course, this listing is merely exemplary and other medical characteristics may be included.

[0100] Also, the controller 1004 is configured to selectively cause balanced stimulation of the opposing pair of muscles within the given patient 1001 so that the opposing pair of muscles is in tension during the cardiac stress test. In particular, each opposing pair of muscles comprises antagonist muscles. For example, the triceps and the biceps are an opposing pair of muscles, and the controller 1004 is configured to cause the triceps and the biceps and to work against each other in substantial equilibrium so that the forearm is substantially motionless.

[0101] The controller 1004 is configured to progressively change stimulation of the opposing pair of muscles within the given patient 1001 during the cardiac stress test. In some embodiments, the progressive change of the stimulation of the opposing pair of muscles may comprise ramps up and ramps down in intensity. Again, regardless of the change in intensity and / or level of the stimulation, the muscles are in substantial equilibrium so that the relevant body part is substantially motionless, for example, to minimize motions that may interfere with comfort, position, or monitoring.

[0102] In some embodiments, the controller 1004 may be configured to change stimulation of the opposing pair of muscles based upon the medical characteristic of the given patient 1001. In other words, these embodiments use a feedback element to control the level of the stimulation. For example, if the medical characteristic of the given patient 1001 exceeds an upper limit threshold / maximum, the level of stimulation may be reduced. If the medical characteristic of the given patient 1001 fails to exceed a lower limit threshold / minimum, the level of stimulation may be increased.

[0103] In some embodiments, each pair of the plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b may comprise a pair of electrical muscle stimulator electrodes. As will be appreciated, the each of electrical muscle stimulator electrodes operates based upon Electrical muscle stimulation (EMS), also known as electromyostimulation or neuromuscular electrical stimulation (NMES), sends electrical impulses to muscles to cause contractions. In other embodiments, each pair of the plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b may comprise a pair of radio frequency muscle stimulation (RFMS) electrodes.

[0104] In yet other embodiments, each pair of the plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b may comprise a pair of magnetic muscle stimulator probes. As will be appreciated, each of magnetic muscle stimulator probes operates based uponelectromagnetic muscle stimulation (EMMS). With RFMS radio frequency signals evoke muscle activations, which may be focused on a target area. With EMMS, a magnetic field induces a current at the muscle level. Either of these methods may lead to intermittent or sustained, nonvolitional contractions. Due to the weak conductive properties of skin, fat, and bone, the electromagnetic field aims to induce a selective contractile stimulus to the muscle layer.

[0105] Further, the controller 1004 may be configured to output a stimulus signal for each of muscle in the opposing pair of muscles. The stimulus signal may comprise one of a burst modulated sine wave signal, a monophasic signal, a biphasic signal, a square-wave signal, a triangle-wave signal, a trapezoid-wave signal, or a pulse train signal, for example. The controller 1004 may be configured to selectively change a level of the stimulus signal during the cardiac stress test.

[0106] Another aspect is directed to a method for performing a cardiac stress test on a given patient 1001. The method comprises positioning a plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b on the given patient 1001. Each pair of muscle stimulator probes 1002a-1002b, 1003a-1003b to be positioned to stimulate an opposing pair of muscles within the given patient 1001. The method also includes operating a controller 1004 coupled to the plurality of pairs of muscle stimulator probes 1002a-1002b, 1003a-1003b to selectively cause stimulation of the opposing pair of muscles within the given patient 1001. The method also includes attaching a plurality of sensor devices 1005a-1005b to the given patient. Each of the plurality of sensor devices 1005a-1005b is coupled to the controller 1004 and is configured to generate a medical characteristic of the given patient 1001 based upon the stimulation of the opposing pair of muscles within the given patient for the cardiac stress test.

[0107] Many modifications and other embodiments of the present disclosure will come to the mind of one skilled in the art having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is understood that the present disclosure is not to be limited to the specific embodiments disclosed, and that modifications and embodiments are intended to be included within the scope of the appended claims.

Claims

CLAIMS:

1. A medical testing device for performing a cardiac stress test on a given patient, with ability to evoke and detect non-physiologic pathologic responses in abnormal patients, the medical testing device comprising: at least one muscle stimulator probe to be positioned on the given patient, the at least one muscle stimulator probe to be positioned to stimulate an opposing pair of muscles within the given patient; a controller coupled to the at least one muscle stimulator probe and configured to selectively cause stimulation of the opposing pair of muscles within the given patient; and at least one sensor device coupled to the controller and attached to the given patient, the at least one sensor device configured to generate a medical characteristic of the given patient based upon the stimulation of the opposing pair of muscles within the given patient for the cardiac stress test.

2. The medical testing device of claim 1 wherein the controller is configured to selectively cause balanced stimulation of the opposing pair of muscles within the given patient so that the opposing pair of muscles is in tension during the cardiac stress test.

3. The medical testing device of claim 1 wherein the controller is configured to progressively change stimulation of the opposing pair of muscles within the given patient during the cardiac stress test.

4. The medical testing device of claim 1 wherein the controller is configured to change stimulation of the opposing pair of muscles based upon the medical characteristic of the given patient.

5. The medical testing device of claim 1 wherein the at least one muscle stimulator probe comprises a pair of muscle stimulator probes, the pair of muscle stimulator probes being one of a pair of electrical muscle stimulator electrodes, a pair of radio frequency muscle stimulator probes, and a pair of magnetic muscle stimulator probes.

6. The medical testing device of claim 1 wherein the at least one sensor device comprises a plurality thereof configured to generate a plurality of medical characteristics of the given patient; and wherein the plurality of medical characteristics of the given patient comprises a blood pressure, a heart rate, and an electrocardiogram.

7. The medical testing device of claim 1 wherein the opposing pair of muscles in the given patient comprises at least one from opposing abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in calves, abductors and adductors in chest, and / or abductors and adductors in abdomen.

8. The medical testing device of claim 1 wherein the controller is configured to output a stimulus signal for each of muscle in the opposing pair of muscles.

9. The medical testing device of claim 8 wherein the stimulus signal comprises one of a burst modulated sine wave signal, a monophasic signal, a biphasic signal, a square-wave signal, a triangle-wave signal, a trapezoid-wave signal, or a pulse train signal.

10. The medical testing device of claim 8 wherein the controller is configured to selectively change a level of the stimulus signal during the cardiac stress test.

11. A medical testing device for performing a cardiac stress test on a given patient, the medical testing device comprising: at least one pair of muscle stimulator probes to be positioned on the given patient, each pair of muscle stimulator probes to be positioned to stimulate an opposing pair of muscles within the given patient; a controller coupled to the at least one pair of muscle stimulator probes and configured to selectively cause balanced stimulation of the opposing pair of muscles within the given patient so that the opposing pair of muscles is in tension during the cardiac stress test; and a plurality of sensor devices coupled to the controller and attached to the given patient, the plurality of sensor devices configured to generate a plurality of medical characteristic of the given patient based upon the stimulation of the opposing pair of muscles within the givenpatient for the cardiac stress test, the plurality of medical characteristics of the given patient comprising a blood pressure, a heart rate, and an electrocardiogram.

12. The medical testing device of claim 11 wherein the controller is configured to progressively change stimulation of the opposing pair of muscles within the given patient during the cardiac stress test.

13. The medical testing device of claim 11 wherein the controller is configured to change stimulation of the opposing pair of muscles based upon the plurality of medical characteristics of the given patient.

14. The medical testing device of claim 11 wherein each pair of muscle stimulator probes comprises one of a pair of electrical muscle stimulator electrodes and a pair of magnetic muscle stimulator probes.

15. The medical testing device of claim 11 wherein the at least one pair of muscle stimulator probes comprises a plurality thereof to be positioned to stimulate a plurality of opposing pairs of muscles within the given patient; and wherein the plurality of opposing pairs of muscles within the given patient comprises opposing abductors and adductors in arms, abductors and adductors in thighs, abductors and adductors in calves, abductors and adductors in chest, and / or abductors and adductors in abdomen.

16. The medical testing device of claim 11 wherein the controller is configured to output a stimulus signal for each of muscle in the opposing pair of muscles.

17. The medical testing device of claim 16 wherein the stimulus signal comprises one of a burst modulated sine wave signal, a monophasic signal, a biphasic signal, a square-wave signal, a triangle-wave signal, a trapezoid-wave signal, or a pulse train signal; and wherein the controller is configured to selectively change a level of the stimulus signal during the cardiac stress test.

18. A method for performing a cardiac stress test on a given patient, with ability to evoke and detect non-physiologic pathologic responses in abnormal patients, the method comprising: positioning at least one muscle stimulator probe on the given patient, the at least one muscle stimulator probe to be positioned to stimulate an opposing pair of muscles within the given patient; operating a controller coupled to the at least one muscle stimulator probe to selectively cause stimulation of the opposing pair of muscles within the given patient; and attaching at least one sensor device to the given patient, the at least one sensor device coupled to the controller and configured to generate a medical characteristic of the given patient based upon the stimulation of the opposing pair of muscles within the given patient for the cardiac stress test.

19. The method of claim 18 further comprising: operating the controller to selectively cause balanced stimulation of the opposing pair of muscles within the given patient so that the opposing pair of muscles is in tension during the cardiac stress test; operating the controller to progressively change stimulation of the opposing pair of muscles within the given patient during the cardiac stress test; and operating the controller to change stimulation of the opposing pair of muscles based upon the medical characteristic of the given patient.

20. The method of claim 18 wherein the at least one muscle stimulator probe comprises a pair of muscle stimulator probes, the pair of muscle stimulator probes being one of a pair of electrical muscle stimulator electrodes, a pair of radio frequency muscle stimulator probes, and a pair of magnetic muscle stimulator probes.

Citation Information

Patent Citations

  • Medical testing device with muscle stimulation cardiac stress test and related methods

    US63500740P0

  • Device

    US20120041513A1

  • Systems For Replicating The Beneficial Effects Of Physical Exercise And Improving Cardiovascular Health

    US20140114117A1

  • Therapeutic muscle stimulation such as for lymphedema

    US20230044828A1